JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamijo, K.
Right arrow Articles by Koelle, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamijo, K.
Right arrow Articles by Koelle, G. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 105, Issue 3, 349-357, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


THE RELATIONSHIP BETWEEN CHOLINESTERASE INHIBITION AND GANGLIONIC TRANSMISSION

Kazuya Kamijo 1 and George B. Koelle 1

1 Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York City

1. The mode of action of DFP at a sympathetic ganglionic site was investigated by recording contractions of the nictitating membrane during preganglionic stimulation in atropinized cats and determining the degrees of inactivation of ganglionic specific and non-specific ChE's.

2. The dose of DFP (0.25 mgm. per kgm. i.v.) which produced complete inactivation of non-specific ChE and 44 per cent inactivation of specific ChE caused no potentiation of the height of contraction or antagonism of intra-arterially injected TEA. At dose levels of 0.5 to 2.0 mgm. per kgm., where specific ChE was progressively inactivated, there was a concomitant increase in the potentiation of contraction and antagonism of TEA. At higher dosage levels, decreased height of contraction and diminished TEA antagonism were usually observed.

3. It is concluded that the action of DFP on the superior cervical ganglion is dependent primarily upon the inhibition of specific ChE.

Submitted on March 10, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.